Vivek Arora

Title: Vivek Arora: Innovator in Cancer Treatment

Introduction

Vivek Arora is a prominent inventor based in New York, NY, who has made significant contributions to the field of cancer research. His work primarily focuses on developing innovative treatments for prostate cancer, particularly targeting the mechanisms that contribute to the disease's progression.

Latest Patents

Vivek Arora holds a patent for "Glucocorticoid inhibitors for treatment of prostate cancer." This invention recognizes that changes in the level and activity of the Glucocorticoid Receptor (GR) are associated with the incidence and risk of Castration Resistant Prostate Cancer (CRPC). The patent outlines the use of GR inhibitors to treat or reduce the risk of CRPC and doubly resistant prostate cancer, especially in patients undergoing antiandrogen therapy. Additionally, the invention provides technologies for identifying agents that can alter GR activity, thereby offering new avenues for treatment.

Career Highlights

Vivek Arora is affiliated with the Sloan Kettering Institute for Cancer Research, where he conducts groundbreaking research aimed at improving cancer therapies. His work has garnered attention for its potential to change the landscape of prostate cancer treatment.

Collaborations

Throughout his career, Vivek has collaborated with esteemed colleagues such as Charles L. Sawyers and Michael J. Evans. These partnerships have further enhanced the impact of his research and innovations in the field.

Conclusion

Vivek Arora's contributions to cancer research, particularly through his patent on glucocorticoid inhibitors, highlight his commitment to advancing treatment options for prostate cancer. His work continues to inspire and pave the way for future innovations in oncology.